METTL13 and acute myeloid leukemia: Consistent with our above results in vitro, METTL13-KD mice showed a slower rate of weight loss (Fig. 4C) and prolonged survival time compared to the control group (Fig. 4D), suggesting that METTL13 promotes the survival of AML cells in vivo.